Announcements Trials
Browse Landscape

Phase

Phase 2 94Phase NA 19Phase 1 17Phase 3 13Phase 1/2 11Phase 2/3 6Phase EARLY_PHASE1 2Phase 4 1

Status

Recruiting 4Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 1Other solid neoplasm 1Dermatologic 1

Conditions

Stomach Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neoplasms 1Melanoma 1Locally Advanced Rectal Adenocarcinoma 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 98Gemcitabine 66Paclitaxel 62Carboplatin 60Fluorouracil 59Docetaxel 59Capecitabine 59Oxaliplatin 56Cyclophosphamide 54Radiotherapy 50Drug Therapy 46Bevacizumab 38pembrolizumab 35Dexamethasone 33Magnetic Resonance Spectroscopy 32Leucovorin 32Doxorubicin 31Cytarabine 27Etoposide 26Pemetrexed 25Nivolumab 24Methotrexate 24Radiation 20Vincristine 18venetoclax 17apatinib 17Rituximab 17Prednisone 17Letrozole 17Irinotecan 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2/3 × Interventional × Immunotherapy × Clear all
NCT07596290 2026-05-22

RADICAL

Beijing Friendship Hospital

Phase 2/3 Not yet recruiting
342 enrolled
Gastrointestinal

Locally Advanced Rectal Adenocarcinoma

NCT07000253 2026-05-07

OMEC-5

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2/3 Recruiting
290 enrolled
Gastrointestinal

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

NCT06624644 2026-04-22

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

Linnaeus Therapeutics, Inc.

Phase 2/3 Recruiting
135 enrolled
Dermatologic

Melanoma

NCT07034326 2025-06-24

Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

Phase 2/3 Recruiting
405 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06907602 2025-04-02

ONTRESCC

Peking Union Medical College Hospital

Phase 2/3 Recruiting
120 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05955157 2024-01-10

Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma

University of Malaya

Phase 2/3 Unknown
52 enrolled
GastrointestinalOther solid neoplasm

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡